Inventor · disambiguated record
Stefan Winge
Also filed as: WINGE STEFAN
20 granted patents·6 pending applications·192 citations·filing 1994–2021
94Inventor score
Files withOCTAPHARMA AG10BIOVITRUM AB4GILLJAM GUSTAV3ESPERION THERAPEUTICS INC2OCTAPHARMA AG A CORP OF SWITZE2
Top patents by PatentIndex Score
26 records- 0193US6399357B1FiltrationBIOVITRUM AB·Filed 2000·Granted Jun 4, 2002·31 cites·59 claims
- 0291US6423830B1Process for purifying apolipoprotein A or apolipoprotein EESPERION THERAPEUTICS INC·Filed 2000·Granted Jul 23, 2002·39 cites·7 claims
- 0385US6451978B2Purification of antithrombin-III-α and βBIOVITRUM AB·Filed 2001·Granted Sep 17, 2002·12 cites·20 claims
- 0482US6090921AProcess for purifying apolipoprotein a or apolipoprotein eESPERION THERAPEUTICS INC·Filed 1997·Granted Jul 18, 2000·45 cites·24 claims
- 0581US9453045B2Process for the purification of a growth factor proteinGILLJAM GUSTAV·Filed 2011·Granted Sep 27, 2016·6 cites·18 claims
- 0681US8329871B2Process of purifying coagulation factor VIIIBORGVALL CARIN·Filed 2009·Granted Dec 11, 2012·19 cites·22 claims
- 0779US6518406B1Method for purification of proteinsOCTAPHARMA AG·Filed 2000·Granted Feb 11, 2003·4 cites·11 claims
- 0871US10214575B2Process for the purification of a growth factor proteinOCTAPHARMA AG·Filed 2016·Granted Feb 26, 2019·1 cites·17 claims
- 0967US9296799B2Process for isolation and purification of a target protein free of prion protein (PrPSC)GILLJAM GUSTAV·Filed 2008·Granted Mar 29, 2016·1 cites·4 claims
- 1065US11738069B2Polypeptides modulating SIGLEC dependent immune responsesOCTAPHARMA AG·Filed 2021·Granted Aug 29, 2023·0 cites·25 claims
- 1164US6486306B1FiltrationBIOVITRUM AB·Filed 1995·Granted Nov 26, 2002·10 cites·58 claims
- 1262US5817765APurification of plasma proteinsPHARMACIA & UPJOHN AB·Filed 1994·Granted Oct 6, 1998·23 cites·23 claims
- 1361US2003191292A1FiltrationOCTAPHARMA AG A CORP OF SWITZE·Filed 2002·Application pending·0 cites
- 1459US12171808B2Glycosylated VWF fusion proteins with improved pharmacokineticsOCTAPHARMA AG·Filed 2017·Granted Dec 24, 2024·0 cites·28 claims
- 1556US10626431B2Method for improved isolation of recombinantly produced proteinsOCTAPHARMA AG·Filed 2016·Granted Apr 21, 2020·0 cites·12 claims
- 1656US2003083471A1Method for purification of proteinsBIOVITRUM AB·Filed 2002·Application pending·0 cites
- 1756US2005203285A1FiltrationOCTAPHARMA AG A CORP OF SWITZE·Filed 2005·Application pending·0 cites
- 1855US8962813B2Purification and use of a factor for supporting wound healingNEISSER-SVAE ANDREA·Filed 2007·Granted Feb 24, 2015·1 cites·18 claims
- 1950US11013789B2Polypeptides modulating SIGLEC dependent immune responsesOCTAPHARMA AG·Filed 2017·Granted May 25, 2021·0 cites·27 claims
- 2048US2016152661A1Process for isolation and purification of a target protein free of prion protein (prpsc)OCTAPHARMA AG·Filed 2015·Application pending·0 cites
- 2147US9388402B2Method for improved isolation of recombinantly produced proteinsWINGE STEFAN·Filed 2006·Granted Jul 12, 2016·0 cites·15 claims
- 2244US10251940B2Preparation comprising factor VIII and Von Willebrand factor peptidesOCTAPHARMA AG·Filed 2015·Granted Apr 9, 2019·0 cites·19 claims
- 2338US10889630B2Method of separating Factor VIII from blood productsOCTAPHARMA AG·Filed 2017·Granted Jan 12, 2021·0 cites·17 claims
- 2436US2014051839A1Process for Reduction and/or Removal of FXI and FXIa from Solutions Containing said Coagulation FactorsSCHULTZ PETRA·Filed 2011·Application pending·0 cites
- 2535US2013079498A1Process for purifying vitamin k dependent proteins such as coagulation factor ixGILLJAM GUSTAV·Filed 2011·Application pending·0 cites
- 2623US10822393B2Process for manufacturing factor VIII having an improved ratio of FVIII:C/FVIII/AGOCTAPHARMA AG·Filed 2015·Granted Nov 3, 2020·0 cites·15 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →